DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
1-Year Est. Return 0.48%
This Quarter Est. Return
1 Year Est. Return
-0.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$362M
AUM Growth
+$9.59M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
86
New
Increased
Reduced
Closed

Top Buys

1 +$2.11M
2 +$1.37M
3 +$1.04M
4
BCAX
Bicara Therapeutics
BCAX
+$975K
5
DAWN icon
Day One Biopharmaceuticals
DAWN
+$961K

Top Sells

1 +$3.31M
2 +$3.05M
3 +$2.12M
4
URGN icon
UroGen Pharma
URGN
+$1.96M
5
KALV icon
KalVista Pharmaceuticals
KALV
+$1.93M

Sector Composition

1 Healthcare 85.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBI icon
1
SPDR S&P Biotech ETF
XBI
$6.31B
$34.5M 9.51%
415,505
+11,000
STXS icon
2
Stereotaxis
STXS
$280M
$29M 8.01%
13,680,554
RVMD icon
3
Revolution Medicines
RVMD
$9.38B
$24.9M 6.88%
677,176
+21,000
BPMC
4
DELISTED
Blueprint Medicines
BPMC
$21.6M 5.97%
168,763
+16,500
MRUS icon
5
Merus
MRUS
$7.19B
$21M 5.79%
398,804
-63,000
ATRC icon
6
AtriCure
ATRC
$1.85B
$19.4M 5.36%
592,273
CYTK icon
7
Cytokinetics
CYTK
$7.13B
$13.2M 3.63%
398,100
IDYA icon
8
IDEAYA Biosciences
IDYA
$2.46B
$13M 3.59%
619,090
+29,760
IBB icon
9
iShares Biotechnology ETF
IBB
$6.17B
$13M 3.58%
102,500
ASND icon
10
Ascendis Pharma
ASND
$12.7B
$12.5M 3.46%
72,677
-7,721
XENE icon
11
Xenon Pharmaceuticals
XENE
$3.27B
$9.01M 2.49%
287,939
+14,200
NBIX icon
12
Neurocrine Biosciences
NBIX
$13.7B
$8.88M 2.45%
70,615
-1,000
AXGN icon
13
Axogen
AXGN
$778M
$8.05M 2.22%
741,782
+61,000
KALV icon
14
KalVista Pharmaceuticals
KALV
$586M
$6.58M 1.82%
581,757
-170,602
DXCM icon
15
DexCom
DXCM
$26B
$5.72M 1.58%
65,552
DAWN icon
16
Day One Biopharmaceuticals
DAWN
$797M
$5.71M 1.58%
879,163
+147,800
STOK icon
17
Stoke Therapeutics
STOK
$1.9B
$5.7M 1.57%
501,972
+57,974
TNDM icon
18
Tandem Diabetes Care
TNDM
$1.04B
$5.48M 1.51%
294,208
RCUS icon
19
Arcus Biosciences
RCUS
$1.76B
$5.11M 1.41%
627,626
+2,500
SNDX icon
20
Syndax Pharmaceuticals
SNDX
$1.31B
$5.09M 1.41%
543,602
-900
MLYS icon
21
Mineralys Therapeutics
MLYS
$3.3B
$5.03M 1.39%
371,523
+62,323
URGN icon
22
UroGen Pharma
URGN
$811M
$4.79M 1.32%
349,515
-143,000
INGN icon
23
Inogen
INGN
$233M
$4.26M 1.18%
605,625
+147,560
GLPG icon
24
Galapagos
GLPG
$2.27B
$3.64M 1.01%
130,175
BHVN icon
25
Biohaven
BHVN
$1.75B
$3.32M 0.92%
235,235
+15,000